NR-SAFE: Safety of High-dose Nicotinamide Riboside (NR) in Parkinson's Disease

Clinical trial NCT05344404 · COMPLETED

Trial details

NCT number: NCT05344404
Sponsor: Haukeland University Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2022-04-29
Primary completion: 2022-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.